GSK3B and pulmonary fibrosis: According to the node degrees in our constructed core component-target network, PTGS2, NOS2, CDK2, GSK3B, CCNA2, PPARG, MAPK14, CASP3, BCL2, and RELA were suggested as core targets of FXF for the treatment of pulmonary fibrosis.